Experimental evaluation of antituberculous compounds, with special reference to the effect of combined treatment.
D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin